Baxter International (BAX) Current Deferred Revenue (2021 - 2024)

Baxter International (BAX) has 4 years of Current Deferred Revenue data on file, last reported at $171.0 million in Q4 2024.

• Current Deferred Revenue for Q4 2024 came in at $171.0 million, up 1.18% year-over-year; the trailing twelve-month figure through Dec 2024 was $171.0 million (up 1.18% YoY), and the FY2024 annual result was $171.0 million, up 1.18% from the prior year.
• Current Deferred Revenue advanced to $171.0 million in Q4 2024 per BAX's latest filing, from $169.0 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $196.0 million in Q4 2021 and troughed at $169.0 million in Q4 2023.
• A 4-year average of $177.2 million and a median of $172.0 million in 2022 frame the typical range for Current Deferred Revenue.
• The sharpest annual moves came in 2022 and 2024: Current Deferred Revenue slipped 11.73% in 2022, then advanced 1.18% in 2024.
• A 4-year view of Current Deferred Revenue shows it stood at $196.0 million in 2021, then decreased by 11.73% to $173.0 million in 2022, then slipped by 2.31% to $169.0 million in 2023, then advanced by 1.18% to $171.0 million in 2024.
• Business Quant data shows BAX's Current Deferred Revenue at $171.0 million in Q4 2024, $169.0 million in Q4 2023, and $173.0 million in Q4 2022.